YAP1 and lung carcinoma: The dysregulation of the Hippo signaling pathway results in the activation of YAP, which promotes the progression of various types of human cancers, including lung cancer, mesothelioma, breast cancer, liver cancer, neural tumors, gastric cancer, ovarian cancer, urogenital cancer, and skin cancer [27–36].